Please assess the completion status of the following clinical trial:

Trial Title: Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute lithiasic cholecystitis low or moderately severe (confined to the gall bladder)~* Requiring early cholecystectomy (progression of symptoms \<5 days~* In an adult patient (\>18 years)~* For each patient included the consent form must have been read, understood and signed.~Exclusion Criteria:~* Severe acute cholecystitis (with organ dysfunction)~* Acalculous cholecystitis~* Biliary peritonitis~* Abscess perivesicular~* Cholangitis~* Acute Pancreatitis~* Septic shock~* Stone of bile duct~* Physical or mental state does not allow participation in the study~* Contraindication to surgery~* Classification ASA (American Society of Anesthesiologists) IV-V or life expectancy \<48 hours~* Suspected pre-or intraoperative cancer of the gallbladder~* Pregnancy or breastfeeding~* Treatment course with methotrexate, imidazole~* Known history of allergy to Augmentin ®

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Amoxicillin clavulanic acid (Type: ACTIVE_COMPARATOR): Postoperative administration of 2g of Augmentin, 3 times daily for 5 days.
- No medication (Type: OTHER): no postoperative antibiotics

Based on this trial design, predict the completion outcome and termination type (if applicable).